Black ethnicity predicts better survival on dialysis despite greater deprivation and co-morbidity: A UK study

Clinical Nephrology

Volumn 82, Issue 2, 2014, Pages 77-82

  Cole, Nicholas ^a   Bedford, Michael ^a   Cai, Andrew ^a   Jones, Chris ^a   Cairns, Hugh ^a   Jayawardene, Satish ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Deprivation; Diabetes; Dialysis; End; Ethnicity; Mortality; Stage renal disease; Survival

Indexed keywords

ADULT; ARTICLE; BLACK PERSON; CARDIOVASCULAR DISEASE; CAUCASIAN; COMORBIDITY; DIABETES MELLITUS; DIALYSIS; END STAGE RENAL DISEASE; ETHNIC GROUP; ETHNICITY; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RENOVASCULAR DISEASE; RETROSPECTIVE STUDY; SOCIAL ISOLATION; SURVIVAL; TRANSPLANTATION; UNITED KINGDOM; CONTROLLED STUDY; KIDNEY TRANSPLANTATION; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

AFRICAN CONTINENTAL ANCESTRY GROUP; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GREAT BRITAIN; HEALTHCARE DISPARITIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84904660128     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN108247     Document Type: Article

References (23)

1. US Renal Data System. USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MA: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2011.
2. Pei YP, Greenwood CM, Chery AL, Wu GG. Racial differences in survival of patients on dialysis. Kidney Int. 2000; 58: 1293-1299.
3. Mesler DE, McCarthy EP, Byrne-Logan S, Ash AS, Moskowitz MA. Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment? Am J Med. 1999; 106: 300-306.
4. Kucirka LM, Grams ME, Lessler J, Hall EC, James N, Massie AB, Montgomery RA, Segev DL. Association of race and age with survival among patients undergoing dialysis. JAMA. 2011; 306:620-626.
5. van den Beukel TO, Dekker FW, Siegert CEH. Increased survival of immigrant compared to native dialysis patients in an urban setting in the Netherlands. Nephrol Dial Transplant. 2008; 23: 3571-3577.
6. Malek SK, Keys BJ, Kumar S, Milford E, Tullius SG. Racial and ethnic disparities in kidney transplantation. Transpl Int. 2011; 24: 419-424. Cross-Ref PubMed
7. Mehrotra R, Kermah D, Fried L, Adler S, Norris K. Racial differences in mortality among those with CKD. J Am Soc Nephrol. 2008; 19: 1403-1410.
8. Jesky M, Lambert A, Burden ACF, Cockwell P. The impact of chronic kidney disease and cardiovascular comorbidity on mortality in a multiethnic population: a retrospective cohort study. BMJ Open. 2013; 3: e003458
9. Prasad S, Singh S, Duncan N, Cairns TD, Griffith M, Hakim N, McLean AG, Palmer A, Papalois V, Taube D. Ethnicity and survival on dialysis in west London. Kidney Int. 2004; 66: 2416-2421.
10. Jain P, Cockwell P, Little J, Ferring M, Nicholas J, Richards N, Higgins R, Smith S. Survival and transplantation in end-stage renal disease: a prospective study of a multiethnic population. Nephrol Dial Transplant. 2009; 24: 3840-3846.
11. Roderick P, Byrne C, Casula A, Steenkamp R, Ansell D, Burden R, Nitsch D, Feest T. Survival of patients from South Asian and Black populations starting renal replacement therapy in England and Wales. Nephrol Dial Transplant. 2009; 24: 3774-3782.
12. UK Renal Registry. UK Renal Registry Report 2010. Bristol: UK Renal Registry; 2010.
13. The Department for Communities and Local Government:The English Indices for Deprivation, 2007.
14. Caskey FJ, Roderick P, Steenkamp R, Nitsch D, Thomas K, Ansell D, Feest T. Social deprivation and survival on renal replacement therapy in England and Wales. Kidney Int. 2006; 70: 2134-2140.
15. NHS Blood and Transplant. Organ Donation and Transplantation: Activity Report 2011/12. Bristol:NHS Blood and Transplant, 2012.
16. Volkova N, McClellan W, Soucie JM, Schoolwerth A. Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients. Nephrol Dial Transplant. 2006; 21: 2202-2209.
17. Parekh RS, Zhang L, Fivush BA, Klag MJ. Incidence of atherosclerosis by race in the dialysis morbidity and mortality study: a sample of the US ESRD population. J Am Soc Nephrol. 2005; 16:1420-1426.
18. Young BA, Rudser K, Kestenbaum B, Seliger SL, Andress D, Boyko EJ. Racial and ethnic differences in incident myocardial infarction in endstage renal disease patients: The USRDS. Kidney Int. 2006; 69: 1691-1698.
19. Xue JL, Frazier ET, Herzog CA, Collins AJ. Association of heart disease with diabetes and hypertension in patients with ESRD. Am J Kidney Dis. 2005; 45: 316-323.
20. Goldberg AP, Harter HR, Patsch W, Schechtman KB, Province M, Weerts C, Kuisk I, McCrate MM, Schonfeld G. Racial differences in plasma highdensity lipoproteins in patients receiving hemodialysis. A possible mechanism for accelerated atherosclerosis in white men. N Engl J Med. 1983; 308: 1245-1252.
21. Bostrom MA, Freedman BI. The spectrum of MYH9-associated nephropathy. Clin J Am Soc Nephrol. 2010; 5: 1107-1113.
22. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010; 329: 841-845.
23. Freedman BI, Murea M. Target organ damage in African American hypertension: role of APOL1. Curr Hypertens Rep. 2012; 14: 21-28.